GlassScriptPhysician profile
Sapna R Patel
NPI 1801830732
$6,842.96
in general payments reported to CMS, 2019-2025
68 companies · $1,608 in 2025
The $1,608 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,277 · 2020: $98.22 · 2021: $57.90 · 2022: $312 · 2023: $555 · 2024: $1,935 · 2025: $1,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,467 · Education: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,467.04 |
| Education | $631.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $634.14 | 2019-2025 | Xtandi, Xospata, Padcev |
| Novartis Pharmaceuticals Corporation | $510.57 | 2019-2025 | |
| Genentech USA, INC. | $433.87 | 2019-2025 | Columvi, Lunsumio, Polivy |
| Janssen Biotech, INC. | $405.49 | 2019-2025 | Rybrevant, Erleada, Darzalex |
| Astrazeneca Pharmaceuticals LP | $390.46 | 2019-2025 | Lynparza, Onglyza, Calquence |
| Tempus Ai, INC | $304.80 | 2024-2025 | Xt Cdx, Tempus Pixel |
| Pfizer INC. | $269.84 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $266.83 | 2019-2025 | Keytruda, Lynparza |
| Daiichi Sankyo INC. | $237.90 | 2024-2025 | Enhertu, Injectafer, Datroway |
| Novocure Gmbh | $200.00 | 2022 | |
| Eisai INC. | $190.04 | 2019-2025 | |
| Foundation Medicine, INC. | $183.25 | 2019 | |
| Celgene Corporation | $167.07 | 2019-2025 | Reblozyl, Opdivo |
| Genzyme Corporation | $156.51 | 2019-2025 | |
| Seagen INC. | $141.82 | 2023-2025 | Tukysa, Tivdak |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sapna Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.